Brief: Design Therapeutics Inc Reports Qtrly Loss Per Share $0.27
08/08/2022 23:30
Aug 8 (Reuters) - Design Therapeutics Inc DSGN.O :
* DESIGN THERAPEUTICS HIGHLIGHTS UPCOMING MILESTONES AND
REPORTS
SECOND QUARTER 2022 FINANCIAL RESULTS
* DESIGN THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.27
Source text for Eikon: ID:nGNX3p8C1C
Further company coverage: DSGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1